Sanofi SA (SNY)
45.82
-0.42
(-0.92%)
USD |
NASDAQ |
Apr 16, 16:00
45.82
0.00 (0.00%)
After-Hours: 19:29
Sanofi Total Return Price: 45.82 for April 16, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| April 15, 2024 | 46.24 |
| April 12, 2024 | 45.93 |
| April 11, 2024 | 46.60 |
| April 10, 2024 | 47.13 |
| April 09, 2024 | 47.53 |
| April 08, 2024 | 47.15 |
| April 05, 2024 | 47.25 |
| April 04, 2024 | 47.80 |
| April 03, 2024 | 47.96 |
| April 02, 2024 | 47.70 |
| April 01, 2024 | 48.29 |
| March 28, 2024 | 48.60 |
| March 27, 2024 | 49.54 |
| March 26, 2024 | 49.75 |
| March 25, 2024 | 49.44 |
| March 22, 2024 | 48.07 |
| March 21, 2024 | 47.73 |
| March 20, 2024 | 48.23 |
| March 19, 2024 | 47.48 |
| March 18, 2024 | 47.83 |
| March 15, 2024 | 48.29 |
| March 14, 2024 | 48.09 |
| March 13, 2024 | 48.24 |
| March 12, 2024 | 48.46 |
| March 11, 2024 | 48.35 |
| Date | Value |
|---|---|
| March 08, 2024 | 48.25 |
| March 07, 2024 | 48.06 |
| March 06, 2024 | 47.68 |
| March 05, 2024 | 47.50 |
| March 04, 2024 | 47.15 |
| March 01, 2024 | 47.29 |
| February 29, 2024 | 47.85 |
| February 28, 2024 | 48.00 |
| February 27, 2024 | 48.21 |
| February 26, 2024 | 48.20 |
| February 23, 2024 | 48.77 |
| February 22, 2024 | 47.80 |
| February 21, 2024 | 47.92 |
| February 20, 2024 | 46.85 |
| February 16, 2024 | 46.18 |
| February 15, 2024 | 46.39 |
| February 14, 2024 | 45.80 |
| February 13, 2024 | 45.75 |
| February 12, 2024 | 46.34 |
| February 09, 2024 | 46.50 |
| February 08, 2024 | 46.56 |
| February 07, 2024 | 46.92 |
| February 06, 2024 | 47.06 |
| February 05, 2024 | 46.95 |
| February 02, 2024 | 47.23 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
32.78
Minimum
Mar 20 2020
55.20
Maximum
Sep 20 2023
45.36
Average
45.86
Median
Aug 17 2020
Total Return Price Benchmarks
| AstraZeneca PLC | 68.26 |
| GSK PLC | 39.95 |
| Novo Nordisk A/S | 123.43 |
| Regeneron Pharmaceuticals Inc | 894.28 |
| Inhibrx Inc | 34.64 |